Welcome to Labeled Immunoassays and Clinical Medicine website!

Detection of Serum Osteocalcin and β-CrossLaps Levels in Gestational Diabetes Mellitus

Expand
  • Department of Clinical Laboratory, The 306th Hospital of PLA, Beijing 100101, China

Received date: 2014-05-30

  Revised date: 2014-10-28

  Online published: 2015-01-25

Abstract

Abstract: Objective To investigate the characteristic of serum osteocalcin and β-CrossLaps level in gestational diabetes mellitus. Methods 30 gestational diabetic patients (GDM group) and 30 pregnant women with normal glucose tolerance (NGT group) were included in this study. The levels of serum glucose, N-MID osteocalcin and β-crosslaps were detected and compared. Results Serum N-MID osteocalcin and β-crosslaps levels in GDM group were significantly higher than those in NGT group (P=0.017 and P=0.018, respectively). Conclusion Bone resorption and turnover level in gestational diabetic patients are higher than pregnant women with normal glucose tolerance.

Cite this article

LI Dan, TIAN Lu, LIU Chun-lei, LI Ting, HUANG Yan-jie1, CHEN Xing-ming1, JING Hua . Detection of Serum Osteocalcin and β-CrossLaps Levels in Gestational Diabetes Mellitus[J]. Labeled Immunoassays and Clinical Medicine, 2015 , 22(1) : 10 . DOI: 10.11748/bjmy.issn.1006-1703.2015.01.004

Outlines

/